| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Adenosine receptor A2a |
|---|
| Ligand | BDBM50080389 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_27479 (CHEMBL633041) |
|---|
| Ki | 1150±n/a nM |
|---|
| Citation |  Knutsen, LJ; Lau, J; Petersen, H; Thomsen, C; Weis, JU; Shalmi, M; Judge, ME; Hansen, AJ; Sheardown, MJ N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects. J Med Chem42:3463-77 (1999) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Adenosine receptor A2a |
|---|
| Name: | Adenosine receptor A2a |
|---|
| Synonyms: | AA2AR_RAT | ADENOSINE A2a | Adenosine A2 receptor | Adenosine A2a receptor (A2a) | Adenosine Receptors A2a (A2a) | Adenosine receptor A2a and A3 | Adenosine receptors A2a | Adora2a | Rat striatal adenosine A2a receptor |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 45015.65 |
|---|
| Organism: | Rattus norvegicus (rat) |
|---|
| Description: | Rat A2A receptors expressed in CHO cells. |
|---|
| Residue: | 410 |
|---|
| Sequence: | MGSSVYITVELAIAVLAILGNVLVCWAVWINSNLQNVTNFFVVSLAAADIAVGVLAIPFA
ITISTGFCAACHGCLFFACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGVRAKG
IIAICWVLSFAIGLTPMLGWNNCSQKDGNSTKTCGEGRVTCLFEDVVPMNYMVYYNFFAF
VLLPLLLMLAIYLRIFLAARRQLKQMESQPLPGERTRSTLQKEVHAAKSLAIIVGLFALC
WLPLHIINCFTFFCSTCRHAPPWLMYLAIILSHSNSVVNPFIYAYRIREFRQTFRKIIRT
HVLRRQEPFQAGGSSAWALAAHSTEGEQVSLRLNGHPLGVWANGSATHSGRRPNGYTLGL
GGGGSAQGSPRDVELPTQERQEGQEHPGLRGHLVQARVGASSWSSEFAPS
|
|
|
|---|
| BDBM50080389 |
|---|
| n/a |
|---|
| Name | BDBM50080389 |
|---|
| Synonyms: | (2S,3S,4R,5R)-2-Chloromethyl-5-[2-chloro-6-(4-phenylsulfanyl-piperidin-1-ylamino)-purin-9-yl]-tetrahydro-furan-3,4-diol | CHEMBL117974 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H24Cl2N6O3S |
|---|
| Mol. Mass. | 511.425 |
|---|
| SMILES | O[C@@H]1[C@@H](CCl)O[C@H]([C@@H]1O)n1cnc2c(NN3CCC(CC3)Sc3ccccc3)nc(Cl)nc12 |
|---|
| Structure | 
|
|---|
Search and Browse
